D.A. DAVIDSON & CO. - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 918 filers reported holding NOVARTIS A G in Q3 2015. The put-call ratio across all filers is 1.29 and the average weighting 0.6%.

Quarter-by-quarter ownership
D.A. DAVIDSON & CO. ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$50,642,536
+1.1%
497,177
+0.1%
0.55%
+4.0%
Q2 2023$50,102,645
+5.3%
496,508
-4.0%
0.53%
-1.1%
Q1 2023$47,599,019
+7.6%
517,409
+6.1%
0.54%
+2.5%
Q4 2022$44,248,291
+20.3%
487,684
+0.8%
0.52%
+8.3%
Q3 2022$36,782,000
-8.2%
483,865
+2.1%
0.48%
-4.2%
Q2 2022$40,052,000
-2.8%
473,822
+0.9%
0.50%
+12.0%
Q1 2022$41,206,000
+4.8%
469,585
+4.5%
0.45%
+7.2%
Q4 2021$39,314,000
+10.8%
449,462
+3.6%
0.42%
+1.7%
Q3 2021$35,478,000
-9.6%
433,824
+0.8%
0.41%
-10.4%
Q2 2021$39,267,000
+11.4%
430,369
+4.3%
0.46%
+2.0%
Q1 2021$35,258,000
+6.0%
412,476
+17.0%
0.45%
-11.4%
Q4 2020$33,277,000
+12.6%
352,404
+3.7%
0.51%
-1.0%
Q3 2020$29,544,000
+3.4%
339,747
+3.9%
0.51%
-3.6%
Q2 2020$28,568,000
-9.1%
327,091
-14.2%
0.53%
-13.2%
Q1 2020$31,443,000
-6.7%
381,397
+7.2%
0.61%
+12.7%
Q4 2019$33,698,000
+14.1%
355,884
+4.7%
0.54%
+3.0%
Q3 2019$29,525,000
-1.7%
339,761
+3.2%
0.53%
-5.5%
Q2 2019$30,048,000
-34.9%
329,074
-31.7%
0.56%
-29.5%
Q1 2019$46,186,000
+13.7%
481,845
+1.8%
0.79%
+0.3%
Q4 2018$40,605,000
+2.1%
473,192
+2.5%
0.79%
+12.0%
Q3 2018$39,765,000
+19.6%
461,525
+4.9%
0.71%
+8.4%
Q2 2018$33,241,000
-4.4%
440,050
+2.3%
0.65%
-9.3%
Q1 2018$34,775,000
-2.2%
430,116
+1.5%
0.72%
-3.6%
Q4 2017$35,562,000
-19.7%
423,552
-17.9%
0.75%
-14.2%
Q3 2017$44,309,000
+3.5%
516,129
+0.7%
0.87%
-10.1%
Q2 2017$42,799,000
+25.9%
512,752
+12.0%
0.97%
+17.4%
Q1 2017$33,991,000
+14.4%
457,680
+12.2%
0.82%
+22.3%
Q4 2016$29,719,000
-1.8%
408,062
+6.4%
0.67%
-10.5%
Q3 2016$30,267,000
+7.6%
383,406
+12.4%
0.75%
-9.1%
Q2 2016$28,135,000
+26.8%
341,078
+11.3%
0.83%
+19.8%
Q1 2016$22,197,000
-10.4%
306,500
+6.4%
0.69%
-14.4%
Q4 2015$24,771,000
-1.0%
287,968
+5.8%
0.81%
-7.9%
Q3 2015$25,025,000
-5.4%
272,282
+1.2%
0.88%
+0.8%
Q2 2015$26,444,000
+0.2%
268,967
+0.5%
0.87%
+0.3%
Q1 2015$26,393,000
+3.2%
267,692
-3.0%
0.87%
+3.6%
Q4 2014$25,567,000
-0.7%
275,997
+0.9%
0.84%
-4.1%
Q3 2014$25,743,000
+7.3%
273,527
+3.2%
0.87%
+7.4%
Q2 2014$23,986,000
+16.8%
265,000
+9.7%
0.81%
+10.6%
Q1 2014$20,541,000
+14.6%
241,669
+8.3%
0.73%
+9.6%
Q4 2013$17,931,000
+9.2%
223,140
+4.2%
0.67%
-9.3%
Q3 2013$16,427,000
+16.3%
214,198
+7.1%
0.74%
+8.4%
Q2 2013$14,130,000199,9140.68%
Other shareholders
NOVARTIS A G shareholders Q3 2015
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders